Reach Us +1-217-403-9671
Blood And Blood Products: Ethical And Legal Aspects In India | 7475
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Blood and blood products: Ethical and legal aspects in India

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Vikas Lodha, B. P. Nagori and Vipin Mathur

Posters: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.007

Human blood is covered under the definition of ?Drug? under Sec. 3(b) of Drugs & Cosmetics Act. Therefore, blood banks and blood transfusion service are regulated under the Drugs & Cosmetics Act and rules thereunder. In order to improve the standards of Blood and its components, the Government of India has formulated a comprehensive legislation to ensure better quality control system on collection, storage, testing and distribution of blood and its components. Part X B of Drugs & Cosmetics Rules prescribes the requirements for the collection, storage, processing and distribution of whole human blood, human blood components by blood banks and manufacture of blood products. PART XII B to the Schedule F of Drugs & Cosmetics Rules defines the requirements for the functioning and operation of a blood bank and/or for preparation of blood components, whereas PART XII C prescribes the requirements for manufacture of blood products. In 2002, Government of India published the National Blood Policy. The objective of the policy is to provide safe, adequate quantity of blood, blood components and products. The main aim of the policy is to procure non remunerated regular blood donors by the blood banks. The policy also addresses various issues with regard to technical personnel, research and development and to eliminate profiteering by the blood banks by selling blood. This presentation discusses various ethical and legal aspects involved in the supply of blood and blood products in India.
Mr. Vikas Lodha is presently pursuing M. Pharmacy in Pharmaceutical Management & Regulatory Affairs branch at Lachoo Memorial College of Science & Technology, Pharmacy Wing, Jodhpur, India.